Artificial intelligence (AI) is an astonishingly rapidly growing technology and is already ‘changing the game’ in many fields. Together with Big Data, AI has been…
Creating your networks You may be aware that we have been reviewing the effectiveness of our Affinity Groups and how we can better support valuable connections and collaboration between our…
Jonathan Brüün will be leaving his role as CEO of the British Pharmacological Society in January 2020. He will be taking up a new post as Chief Executive of the Royal College of…
In an Editorial published in the British Journal of Pharmacology (BJP), the Editor-in-Chief and Senior Editors have recommended that all future studies published in the journal should formally…
In August 2018, a review by the Chief Medical Officer recommended moving cannabis-based medicinal products out of Schedule 1 of the Misuse of Drugs Regulations 2001 ('the 2001…
The implementation of the NHS Long-term Plan depends not only on the 5-year funding settlement for NHS England announced in June 2018, but also on the funding settlements covering NHS…
We want to make the membership journey as straightforward as possible for our early career pharmacologist members. At present, there are three membership categories catering to them: Undergraduate…
Autumn has arrived and activity is ramping up at the Society in preparation for our annual meeting, Pharmacology 2019. I am delighted to report that even though the meeting is on the move for the…
